Avita Medical Inc (AVH) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Avita Medical Inc (AVH) has a cash flow conversion efficiency ratio of 0.411x as of December 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (AU$-5.32 Million ≈ $-3.77 Million USD) by net assets (AU$-12.96 Million ≈ $-9.17 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See AVH net asset quality score to measure how much of total assets are equity-financed.
Avita Medical Inc - Cash Flow Conversion Efficiency Trend (1994–2025)
This chart illustrates how Avita Medical Inc's cash flow conversion efficiency has evolved over time, based on yearly financial data. Check AVH operating cash flow to net income to evaluate the quality of earnings relative to operating cash generation.
Avita Medical Inc Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Avita Medical Inc ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Lastminute.com NV
F:09B
|
-0.327x |
|
Currenc Group Inc. Ordinary Shares
NASDAQ:CURR
|
-0.355x |
|
ROKISKIO SURIS PC EO 029
F:YTV
|
N/A |
|
LB Semicon Inc
KQ:061970
|
0.045x |
|
Quantum Corporation
NASDAQ:QMCO
|
0.027x |
|
Hammond Manufacturing Company Limited
TO:HMM-A
|
0.058x |
|
Empro Group Inc. Ordinary shares
NASDAQ:EMPG
|
N/A |
|
Generation Mining Ltd
TO:GENM
|
0.027x |
Annual Cash Flow Conversion Efficiency for Avita Medical Inc (1994–2025)
The table below shows the annual cash flow conversion efficiency of Avita Medical Inc from 1994 to 2025. For the full company profile with market capitalisation and key ratios, see AVH stock market capitalisation.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-06-30 | AU$4.50 Million ≈ $3.18 Million |
AU$-48.94 Million ≈ $-34.63 Million |
-10.878x | -1303.85% |
| 2024-06-30 | AU$49.06 Million ≈ $34.71 Million |
AU$-38.01 Million ≈ $-26.90 Million |
-0.775x | -243.95% |
| 2023-06-30 | AU$124.47 Million ≈ $88.07 Million |
AU$-28.04 Million ≈ $-19.84 Million |
-0.225x | -33.48% |
| 2022-06-30 | AU$147.08 Million ≈ $104.07 Million |
AU$-24.82 Million ≈ $-17.56 Million |
-0.169x | +46.28% |
| 2021-06-30 | AU$72.40 Million ≈ $51.23 Million |
AU$-22.75 Million ≈ $-16.09 Million |
-0.314x | 0.00% |
| 2020-06-30 | AU$104.91 Million ≈ $74.23 Million |
AU$-32.96 Million ≈ $-23.32 Million |
-0.314x | +65.95% |
| 2019-06-30 | AU$20.86 Million ≈ $14.76 Million |
AU$-19.25 Million ≈ $-13.62 Million |
-0.923x | +26.32% |
| 2018-06-30 | AU$13.98 Million ≈ $9.89 Million |
AU$-17.51 Million ≈ $-12.39 Million |
-1.252x | +25.05% |
| 2017-06-30 | AU$5.12 Million ≈ $3.62 Million |
AU$-8.56 Million ≈ $-6.05 Million |
-1.671x | -44.22% |
| 2016-06-30 | AU$6.85 Million ≈ $4.85 Million |
AU$-7.94 Million ≈ $-5.62 Million |
-1.158x | +23.76% |
| 2015-06-30 | AU$4.22 Million ≈ $2.98 Million |
AU$-6.41 Million ≈ $-4.53 Million |
-1.519x | -21.27% |
| 2014-06-30 | AU$5.53 Million ≈ $3.91 Million |
AU$-6.92 Million ≈ $-4.90 Million |
-1.253x | -80.71% |
| 2013-06-30 | AU$10.46 Million ≈ $7.40 Million |
AU$-7.25 Million ≈ $-5.13 Million |
-0.693x | -39.03% |
| 2012-06-30 | AU$8.55 Million ≈ $6.05 Million |
AU$-4.27 Million ≈ $-3.02 Million |
-0.499x | -189.70% |
| 2011-06-30 | AU$16.99 Million ≈ $12.02 Million |
AU$-2.92 Million ≈ $-2.07 Million |
-0.172x | +57.73% |
| 2010-06-30 | AU$3.98 Million ≈ $2.81 Million |
AU$-1.62 Million ≈ $-1.15 Million |
-0.407x | +39.77% |
| 2009-06-30 | AU$6.93 Million ≈ $4.91 Million |
AU$-4.69 Million ≈ $-3.32 Million |
-0.676x | -137.36% |
| 2008-06-30 | AU$12.96 Million ≈ $9.17 Million |
AU$-3.69 Million ≈ $-2.61 Million |
-0.285x | +65.16% |
| 2007-06-30 | AU$10.98 Million ≈ $7.77 Million |
AU$-8.97 Million ≈ $-6.35 Million |
-0.818x | +7.29% |
| 2006-06-30 | AU$11.15 Million ≈ $7.89 Million |
AU$-9.83 Million ≈ $-6.96 Million |
-0.882x | -26.70% |
| 2004-06-30 | AU$8.66 Million ≈ $6.13 Million |
AU$-6.03 Million ≈ $-4.26 Million |
-0.696x | -202.25% |
| 2003-06-30 | AU$8.25 Million ≈ $5.83 Million |
AU$-1.90 Million ≈ $-1.34 Million |
-0.230x | -80.03% |
| 2002-06-30 | AU$4.53 Million ≈ $3.21 Million |
AU$-579.75K ≈ $-410.21K |
-0.128x | +15.36% |
| 2001-06-30 | AU$5.38 Million ≈ $3.81 Million |
AU$-813.24K ≈ $-575.42K |
-0.151x | +38.59% |
| 1999-06-30 | AU$1.10 Million ≈ $781.22K |
AU$-271.66K ≈ $-192.22K |
-0.246x | -79.20% |
| 1997-06-30 | AU$4.98 Million ≈ $3.52 Million |
AU$-683.59K ≈ $-483.68K |
-0.137x | -15.69% |
| 1996-06-30 | AU$4.48 Million ≈ $3.17 Million |
AU$-532.00K ≈ $-376.42K |
-0.119x | +8.92% |
| 1995-06-30 | AU$5.82 Million ≈ $4.12 Million |
AU$-758.00K ≈ $-536.33K |
-0.130x | -1841.18% |
| 1994-06-30 | AU$6.55 Million ≈ $4.63 Million |
AU$49.00K ≈ $34.67K |
0.007x | -- |
About Avita Medical Inc
AVITA Medical, Inc., together with its subsidiaries, operates as a therapeutic acute wound care company in the United States, Japan, the European Union, Australia, and the United Kingdom. The company's lead product is the RECELL System, a cell harvesting device used for the treatment of thermal burn wounds and full-thickness skin defects, as well as for repigmentation of stable depigmented vitili… Read more